Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia
Crossref DOI link: https://doi.org/10.1007/s11136-016-1460-x
Published Online: 2016-11-28
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hakimi, Zalmai
Herdman, Mike
Pavesi, Marco
Devlin, Nancy
Nazir, Jameel
Hoyle, Chris
Odeyemi, Isaac A. O.
Funding for this research was provided by:
Astellas Pharma
License valid from 2016-11-28